HOME >> MEDICINE >> NEWS
NYU'S Duster cautions against FDA approval of 'race-based' pharmaceutical

New York University Sociologist Troy Duster concludes that a pharmaceutical to combat heart disease among blacks is based on faulty research and urges the Food and Drug Administration to obtain more reliable data before approving the drug. Duster, president of the American Sociological Association, writes that research on isosorbide dinitrate and hydralazine (BiDil), produced by NitroMed, incorrectly links a biological idea of race to heart disease and that socioeconomic factors better explain susceptibility to heart disease. Duster's analysis appears in Science magazine.

"Race is such a dominant category in the cognitive field that it can leave its own indelible mark once given even the temporary imprimatur of scientific legitimacy by molecular genetics," Duster writes, expressing concern for the precedent the NitroMed study may set.

However, Duster encourages continued research to match genetics and medical treatment.

"An increased understanding of genetic diversity will help scientists doing gene-association studies by identifying new variants and reducing the likelihood of false-positive associations," he writes. "The hope is that it may aid scientists to identify medically relevant genes for diseases."

Initially, the FDA rejected its use to treat heart disease because of its ineffectiveness among the general population. However, the company began testing BiDil exclusively on blacks with FDA approvalafter theorizing that the drug's effect on nitric-oxide deficiency, which is more common in black heart-failure patients than in non-blacks, would be beneficial to a targeted racial population. NitroMed reported effectiveness of the BiDil in its clinical trial of 400 black women and 600 black men.

NitroMed, which intends to market the drug to African Americans after FDA approval, has noted that African Americans between the ages of 45 and 64 are two-and-a-half times more likely to die from hear
'"/>

Contact: James Devitt
james.devitt@nyu.edu
212-998-6808
New York University
25-Feb-2005


Page: 1 2

Related medicine news :

1. Strategy effective against drug resistant tuberculosis
2. New study in Nature demonstrates protection against cell death during heart attack
3. Vaccine against childhood pneumonia shows promise
4. Mayo Clinic discovers new pathway against pancreatic cancer
5. Orthodontists must brace against back pain
6. Female sex hormones play a vital role in defense against sexually transmitted diseases
7. New European cancer figures for 2004 major efforts needed against the big four killers
8. New highly active agents against sandfly fever
9. New mosquito control strategy proves successful against dengue fever
10. Mayo Clinic researchers create obedient virus; First step to use measles virus against cancer
11. Gene vaccine protects mice against development of Her2/neu breast cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/15/2019)... ... November 15, 2019 , ... DataTribe ... data science companies with nation-state experienced technical teams from the intelligence community, research ... is Code Dx Inc ., based in Northport, New York. ...
(Date:11/14/2019)... ... November 14, 2019 , ... With ... System reminds community members, businesses and organizations about the benefits of supporting local ... that inspires hundreds of millions of people to give, collaborate and celebrate generosity ...
(Date:11/14/2019)... ... November 14, 2019 , ... EMulate Therapeutics, ... serious diseases, announced it will have 5 poster presentations related to its medical ... Society for Neuro-Oncology SNO Meeting in Phoenix, beginning on November 20 . ...
(Date:11/14/2019)... ... November 14, 2019 , ... AstraZeneca and MSD ... acceptance to file status of its application for the MEK inhibitor selumetinib, for ... type one (NF1). The FDA’s acceptance of the application is a major milestone ...
(Date:11/12/2019)... ... November 12, 2019 , ... AI for preventable harm analytics leader Jvion ... AI 2019 - Actualizing the Potential of AI”, which provides a “tip of the ... healthcare-focused AI company with enough clients to complete a full KLAS analysis, Jvion was ...
Breaking Medicine News(10 mins):
(Date:11/19/2019)... RHINELANDER, Wis. (PRWEB) , ... November 18, 2019 ... ... Formulation on Various Health Biomarkers Using Cell-Based Assays” by Elizabeth Patric has been ... myriad categories including Holistic Medicine, Biochemistry, Microbiology, Nosology, Nursing Reference, Research and Theory, ...
(Date:11/19/2019)... ... 19, 2019 , ... Respected Hollywood actor and film director, ... with Laurence Fishburne. The program’s central focus is to inform the general public ... to be aired on the show, a new segment covering TMJD (Temporomandibular Disorder) ...
(Date:11/16/2019)... COLUMBUS, Ohio (PRWEB) , ... November 15, 2019 ... ... and older adults living with memory impairment, has announced the Best Memory Care ... location, access to experts, facility features and amenities. , According to the ...
Breaking Medicine Technology:
Cached News: